Flibanserin: Initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder

Journal of Sexual Medicine

Volumn 7, Issue 10, 2010, Pages 3449-3459

  Kennedy, Sidney ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Female Sexual Dysfunction; Flibanserin; Hypoactive Sexual Desire Disorder; Major Depression Disorder; Serotonin

Indexed keywords

FLIBANSERIN; FLUOXETINE; PAROXETINE; PLACEBO;

ADULT; AGED; ANORGASMIA; ARIZONA SEXUAL EXPERIENCES SCALE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SENSITIVITY; EJACULATION DISORDER; FEMALE; FEMALE SEXUAL DYSFUNCTION; HAMILTON SCALE; HUMAN; IMPOTENCE; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MALE SEXUAL DYSFUNCTION; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SEXUAL FUNCTION; SIDE EFFECT; TREATMENT OUTCOME;

EID: 77957350880     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01938.x     Document Type: Article

References (31)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999, 281:537-44.
2. Moreira ED, Glasser DB, Nicolosi A, Duarte FG, Gingell C. Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe. BJU Int 2008, 101:1005-11.
3. Bonierbale M, Lancon C, Tignol J. The ELIXIR study: Evaluation of sexual dysfunction in 4,557 depressed patients in France. Curr Med Res Opin 2003, 19:114-24.
4. Kennedy SH, Rizvi S. Sexual function, depression and the impact of antidepressants. J Clin Psychopharmacol 2009, 29:157-64.
5. Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: A meta-analysis. J Clin Psychopharmacol 2009, 29:259-66.
6. Kennedy SH, Rizvi S. Sexual functioning and quality of life in patients in remission from depression. Medicographia 2009, 31:146-51.
7. Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000, 57:1012-30.
8. Sicuteri F, Del Bene E, Fonda C. Sex, migraine and serotonin interrelationships. Monogr Neural Sci 1976, 3:94-101.
9. Pfaus JG. Pathways of sexual desire. J Sex Med 2009, 6:1506-33.
10. Nic Dhonnchadha BA, Ripoll N, Clenet F, Hascoet M, Bourin M. Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test. Psychopharmacology (Berl) 2005, 179:418-29.
11. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol 1999, 19:67-85.
12. Ozmenler NK, Karlidere T, Bozkurt A, Yetkin S, Doruk A, Sutcigil L, Cansever A, Uzun O, Ozgen F, Ozsahin A. Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. Hum Psychopharmacol 2008, 23:321-6.
13. Boyarsky BK, Haque W, Rouleau MR, Hirschfeld RM. Sexual functioning in depressed outpatients taking mirtazapine. Depress Anxiety 1999, 9:175-9.
14. Kennedy SH, Rizvi S, Fulton K, Rasmussen J. A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. J Clin Psychopharmacol 2008, 28:329-33.
15. Montejo A, Prieto N, Terleira A. Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale. J Psychopharmacol 2010, 24:111-20.
16. Zajecka J, Dunner DL, Gelenberg AJ, Hirschfeld RM, Kornstein SG, Ninan PT, Rush AJ, Thase ME, Trivedi MH, Arnow BA, Borian FE, Manber R, Keller MB. Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination. J Clin Psychiatry 2002, 63:709-16.
17. Feiger AD, Heiser JF, Shrivastava RK, Weiss KJ, Smith WT, Sitsen JM, Gibertini M. Gepirone extended-release: New evidence for efficacy in the treatment of major depressive disorder. J Clin Psychiatry 2003, 64:243-9.
18. Gelenberg AJ, McGahuey C, Laukes C, Okayli G, Moreno F, Zentner L, Delgado P. Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry 2000, 61:356-60.
19. Borsini F, Evans K, Jason K, Rohde F, Alexander B, Pollentier S. Pharmacology of flibanserin. CNS Drug Rev 2002, 8:117-42.
20. Borsini F, Cesana R. Further characterisation of potential antidepressant action of flibanserin. Psychopharmacology (Berl) 2001, 159:64-9.
21. Clayton AH, Jolly E, Thorp J, Lewis-D'Agostino DJ, Wunderlich G, Lesko L. Baseline characteristics of patients enrolled in three Phase III North American trials of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder. J Sex Med 2009, 6(suppl 2):45.
22. Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Patel P, Mikl J, Sand M, Pyke R. Efficacy of continued flibanserin treatment in premenopausal women with Hypoactive Sexual Desire Disorder: Results from the ROSE Study. J Sex Med 2009, 6(suppl 2):45.
23. Jolly E, Clayton AH, Thorp J, Kimura T, Sand M, Pyke R. Efficacy of Flibanserin 100 mg qhs as a Potential Treatment for Hypoactive Sexual Desire Disorder in Premenopausal Women: European Society for Sexual Medicine-12th Congress. 2009, Lyon, France
24. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
25. McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight M, Manber R. The Arizona Sexual Experience Scale (ASEX): Reliability and validity. J Sex Marital Ther 2000, 26:25-40.
26. Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: Has the gold standard become a lead weight? Am J Psychiatry 2004, 161:2163-77.
27. Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 2000, 61:276-81.
28. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001, 62(suppl 3):10-21.
29. Nofzinger EA, Thase ME, Reynolds CF, Frank E, Jennings JR, Garamoni GL, Fasiczka AL, Kupfer DJ. Sexual function in depressed men. Assessment by self-report, behavioral, and nocturnal penile tumescence measures before and after treatment with cognitive behavior therapy. Arch Gen Psychiatry 1993, 50:24-30.
30. Croft H, Settle E, Houser T, Batey SR, Donahue RM, Ascher JA. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 1999, 21:643-58.
31. Clayton A, Jayne C, Jacobs M, Kimura T, Pyke R, Lewis-D'Agostino D. Efficacy of flibanserin as a potential treatment for Hypoactive Sexual Desire Disorder in North American premenopausal women: Results from the DAHLIA trial. J Sex Med 2009, 6:408.